Generex Biotechnology Engages Jaime Davidson as Medical Director

17-Jul-2006

Generex Biotechnology Corporation announced that it has engaged Dr. Jaime Davidson, MD, FACP, FACE as a consultant Medical Director for the Company.

Dr. Davidson is the President of Endocrine and Diabetes Associates of Texas, based at the Medical City Dallas Hospital complex, and a Clinical Associate Professor of Internal Medicine at University of Texas Southwestern Medical Center in Dallas, Texas.

In 2006 Dr. Davidson was distinguished by the American Association of Clinical Endocrinologists with an award for his contributions to the improvement of endocrine health for under-served populations, and by the American Diabetes Association with the Harold Rifkin MD award for his international contributions in the diabetes field.

His past experience is vast and includes positions with the National Diabetes Advisory Board, the National Institutes of Health, the Centers for Disease Control, the Institute of Medicine, and the boards of directors of the American Diabetes Association, the American Association of Clinical Endocrinologists, and the American College of Endocrinology. He served in higher education for a six year term as a Regent of Midwestern State University in Texas appointed by then Governor George W. Bush. He has also served in the President's Council for Fitness and Sports, chaired the Texas Diabetes Council of the Texas Department of Health for several years where he instituted the Texas Diabetes Algorithm, and under his guidance the Texas Diabetes Institute was established with the University of Texas Health Science Center in San Antonio, Texas.

Dr. Davidson's experience in clinical pharmacology began with a Clinical Pharmacology Fellowship at Lilly Laboratories for Clinical Research and it continued with multiple clinical trials. In addition, he was an advisor to the Food and Drug Administration (FDA) on the Endocrinology and Metabolism Advisory Board.

In his capacity as Medical Director, Dr. Davidson will, among other things: design, implement, and supervise clinical trial protocols; review and interpret scientific data and results; make presentations of the Company's data, results, and conclusions to regulatory agencies and liaise with regulatory agencies to advance the Company's interests; make presentations of the Company's data, results, and conclusions at scientific symposia and to prospective third party strategic alliance partners; and develop, implement, and supervise physician education programs in respect of the Company's extant and prospective products.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances